Clark Estates’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Clark Estates's HRMY Position: Q3 2026 in Review
Clark Estates held its Harmony Biosciences (HRMY) position steady in Q3 2026 at 81,300 shares worth $3.19M. The position accounts for 0.74% of the portfolio, ranked #26.
Clark Estates first reported a position in HRMY in Q1 2025 and has held it in 7 quarters since. 279 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Clark Estates held 81,300 shares of Harmony Biosciences worth $3.19M as of Q3 2026.
- Clark Estates left its Harmony Biosciences share count unchanged in Q3 2026.
- Harmony Biosciences made up 0.74% of Clark Estates's portfolio in Q3 2026, its #26 holding.
- Clark Estates first reported a position in Harmony Biosciences in Q1 2025 and has held it in 7 quarters since.
- 279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Clark Estates's 13F filing for Q3 2026, filed 10 Nov 2026.